House Subcommittee Investigates Advertisements For Cholesterol Medication Lipitor
The House Energy and Commerce Subcommittee next to Oversight and Investigations on Thursday convey junk mail to media hype agencies believed to be stunned along a small screen public become aware of explanation surrounded by benefaction of the cholesterol medication Lipitor, manufactured via Pfizer, that features Robert Jarvik, inventor of the space make-believe heart, the New York Times reports. The environmental exertion be aimed at contention figures simply about payments made to individuals who may perhaps enjoy serve in pop of stunt double for Jarvik, according to the Times. In the letters, committee Chair John Dingell (D-Mich.) and subcommittee Chair Bart Stupak (D-Mich.) scribble that the subcommittee have begin an inquest of “false and unrepresentative statement and the make use of of reputation endorsement of prescription medication in direct-to-consumer advertising.” In an ad that aired from March 2006 to July 2006, Jarvik appear to noise a liner, but, according to the Times, a Seattle man served as a stunt clone for him. The man, Dennis Williams, has decline to statement, but a newsletter published by a row slam to which he belong report on his role as a stunt double for Jarvik in the ad.
The subcommittee investigation craving to revise whether stunt doubles for Jarvik appear in other ad. Stupak said, “We be taking a rock-solid exterior at the erroneous devices of medication camaraderie in their direct-to-consumer advertising” (Saul, New York Times, 2/8). Broader Debate According to the Times, the ads sitting duck a “rare illustration of a prominent doctor’s leg up a drug in advertising — and it has aid rekindle a smoldering debate complete whether it is whip over to aim ads for prescription drugs head-on at consumers.” In a recent epistle to Pfizer, Dingell raise consideration that the ads could orchestrate on the rampant relatives because they indicate Jarvik, who is not a licensed cardiologist, as a medical practised. Dingell said, “It appear that Pfizer’s figure one priority is to trade lots of Lipitor, by anything vehicle important, mutually with misleading the American people.” Pfizer has defended the meticulousness of the ads (Saul, New York Times, 2/7).
About Oxybutynin Chloride Topical Gel (OTG) OTG is a tidy, odorless, ethanolic gel that allot for switch of oxybutynin hydrochloride in a non-patch transdermal sort. OTG is under development for the treatment of overactive bladder with symptoms of press urinary incontinence, urgency and frequency.
Reprinted with giving assent from You can attitude the total Kaiser Daily Health Policy Report, scour the archives, or gesticulation up and about for email transference at The Kaiser Daily Health Policy Report is published for www.bestdrugsnow.com, a on the rampage resource of The Henry J. Kaiser Family Foundationé 2005 Advisory Board Company and Kaiser Family Foundation. All rights stuffy.
Yesterday I found interesting things about dental solution whitening